Related Experiment Video
Updated: Feb 6, 2026
Author Spotlight: Unraveling the Impact of Mechanical Ventilation on Diaphragm Function and Patient Outcomes
Published on: November 3, 2023
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status
Harith Rajagopalan1, Alberto Bardelli, Christoph Lengauer
1Sidney Kimmel Comprehensive Cancer Centre, Howard Hughes Medical Institution and Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Abstract:
Genes of the RAF family encode kinases that are regulated by Ras and mediate cellular responses to growth signals. Activating mutations in one RAF gene, BRAF, have been found in a high proportion of melanomas and in a small fraction of other cancers. Here we show that BRAF mutations in colorectal cancers occur only in tumours that do not carry mutations in a RAS gene known as KRAS, and that BRAF mutation is linked to the proficiency of these tumours in repairing mismatched bases in DNA. Our results not only provide genetic support for the idea that mutations in BRAF and KRAS exert equivalent effects in tumorigenesis, but also emphasize the role of repair processes in establishing the mutation spectra that underpin human cancer.
Insights
Activating BRAF mutations in colorectal cancer are linked to proficient DNA mismatch repair and occur independently of KRAS mutations. This suggests BRAF and KRAS have similar roles in tumor development and highlights DNA repair
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- RAF family genes encode kinases regulating cellular responses to growth signals.
- Activating BRAF mutations are common in melanoma and found in some other cancers.
- RAS proteins regulate RAF kinases and are involved in cell signaling pathways.
Purpose of the Study:
- To investigate the relationship between BRAF mutations and KRAS mutations in colorectal cancers.
- To explore the association between BRAF mutations and DNA repair proficiency in colorectal tumors.
- To understand the distinct roles of BRAF and KRAS in tumorigenesis.
Main Methods:
- Analysis of BRAF and KRAS mutation status in colorectal cancer samples.
- Assessment of DNA mismatch repair (MMR) proficiency in these tumors.
- Correlation of genetic mutation data with MMR status.
Main Results:
- BRAF mutations in colorectal cancer were exclusively found in tumors lacking KRAS mutations.
- A significant link was observed between BRAF mutation and proficient DNA mismatch repair.
- These findings suggest BRAF and KRAS mutations may have equivalent roles in driving cancer development.
Conclusions:
- BRAF and KRAS mutations appear to have interchangeable functions in colorectal cancer initiation.
- DNA repair mechanisms play a crucial role in shaping the mutation landscape of human cancers.
- Understanding these genetic interactions is vital for targeted cancer therapies.
More Related Videos
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 4, 2015
Related Concept Videos
05:51Measuring Diaphragm Thickness and Function Using Point-of-Care Ultrasound
08:47Oral Health Assessment by Lay Personnel for Older Adults
05:17Preparation of High-Quality Fermented Fish Product
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
04:57Proper Care and Cleaning of the Microscope